Assertio Holdings Inc. (ASRT)
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
Microbot Medical Inc (MBOT)
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
Neuraxis Inc (NRXS)
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
Senti Biosciences Inc. (SNTI)
Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia
Liquidia Corporation (LQDA)
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
Soligenix Inc. (SNGX)
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
American Well Corp (AMWL)
Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
Curis Inc (CRIS)
Vivani Medical Inc. (VANI)
Core Molding Technologies Inc (CMT)
New Form 8-K - CORE MOLDING TECHNOLOGIES INC Filed: 2025-08-05 AccNo: 0001026655-25-000069 Size: 397 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Harmony Biosciences (HRMY)
UFP Technologies Inc (UFPT)
Nuwellis Inc. (NUWE)
Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code
Core Molding Technologies Inc (CMT)
Core Molding Technologies Announces 2026 Leadership Transition
Clearmind Medicine Inc (CMND)
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center